Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Iovance Biotherapeutics, Inc. - Common Stock (NQ:IOVA)

2.550 -0.140 (-5.21%)
Streaming Delayed Price Updated: 3:45 PM EDT, Aug 25, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 10,947,531
Open 2.571
Bid (Size) 2.540 (114)
Ask (Size) 2.550 (402)
Prev. Close 2.690
Today's Range 2.510 - 2.660
52wk Range 1.639 - 12.51
Shares Outstanding 305,252,194
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Keurig Dr Pepper, Valneva, Venu Holding And Other Big Stocks Moving Lower On Monday
 
Via Benzinga
1 Beaten-Down Stock That Could Soar By 261%, According to Wall Street
Time is running out for the company to mount a comeback. 
Via The Motley Fool

Performance

YTD
-67.3%
-67.3%
1 Month
-18.5%
-18.5%
3 Month
+47.4%
+47.4%
6 Month
-54.1%
-54.1%
1 Year
-78.6%
-78.6%

More News

Read More
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
From Iovance Biotherapeutics, Inc.
Via GlobeNewswire
Why Iovance Biotherapeutics Stock Was Climbing Today
Via The Motley Fool
Iovance Stock Rises 4% On Health Canada Approval For Cancer Immunotherapy: Retail Thinks ‘Patience Will Pay Off’
Via Stocktwits
Earnings Scheduled For August 7, 2025
Via Benzinga
Intel, Plymouth Industrial REIT, Premier And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Why Palo Alto Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Curious about the stocks that are showing activity after the closing bell on Monday?
Via Chartmill
Iovance’s Amtagvi® (lifileucel) Receives Health Canada Approval for Advanced Melanoma
From Iovance Biotherapeutics, Inc.
Via GlobeNewswire
3 Stocks That Could Turn $1,000 Into $5,000 by 2030
Via The Motley Fool
Why Iovance Biotherapeutics Stock Plummeted Today
Via The Motley Fool
What 7 Analyst Ratings Have To Say About Iovance Biotherapeutics
Via Benzinga
Pinterest Posts Downbeat Q2 Earnings, Joins Twilio, Trade Desk And Other Big Stocks Moving Lower In Friday Pre-Market Session
Via Benzinga
Which stocks are moving before the opening bell on Friday?
Via Chartmill
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Iovance Biotherapeutics Declines 29% In Premarket Trading: Here's What's Happening
Via Benzinga
Why Expedia Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Curious about the stocks that are showing activity after the closing bell on Thursday?
Via Chartmill
Iovance (IOVA) Q2 Revenue Jumps 93%
Via The Motley Fool
Topics Intellectual Property
Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Second Quarter and First Half 2025
From Iovance Biotherapeutics, Inc.
Via GlobeNewswire
Is Iovance Biotherapeutics Stock Due for a Big Rally?
Via The Motley Fool
This Beaten-Down Healthcare Stock Could Jump 720%, According to a Wall Street Analyst. Is It Time to Buy?
Via The Motley Fool

Frequently Asked Questions

Is Iovance Biotherapeutics, Inc. - Common Stock publicly traded?
Yes, Iovance Biotherapeutics, Inc. - Common Stock is publicly traded.
What exchange does Iovance Biotherapeutics, Inc. - Common Stock trade on?
Iovance Biotherapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Iovance Biotherapeutics, Inc. - Common Stock?
The ticker symbol for Iovance Biotherapeutics, Inc. - Common Stock is IOVA on the Nasdaq Stock Market
What is the current price of Iovance Biotherapeutics, Inc. - Common Stock?
The current price of Iovance Biotherapeutics, Inc. - Common Stock is 2.550
When was Iovance Biotherapeutics, Inc. - Common Stock last traded?
The last trade of Iovance Biotherapeutics, Inc. - Common Stock was at 08/25/25 03:45 PM ET
What is the market capitalization of Iovance Biotherapeutics, Inc. - Common Stock?
The market capitalization of Iovance Biotherapeutics, Inc. - Common Stock is 778.36M
How many shares of Iovance Biotherapeutics, Inc. - Common Stock are outstanding?
Iovance Biotherapeutics, Inc. - Common Stock has 778M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.